HCC with tumor thrombus entering the right atrium and inferior vena cava treated by percutaneous ablation

Wei Li1, Yang Wang1, Wenfeng Gao1

  • 1Center of Interventional Oncology and Liver Diseases, Beijing You'an Hospital, Capital Medical University, 8 Xitoutiao, Youanmenwai St., Fengtai Dist., Beijing, 100069, People's Republic of China.

BMC Surgery
|March 2, 2017
PubMed

Insights

Percutaneous microwave ablation offers a novel treatment for advanced hepatocellular carcinoma (HCC) with tumor thrombus (TT) extending into the right atrium and inferior vena cava. This minimally invasive approach demonstrated positive outcomes in a rare case, suggesting its potential utility.

Area of Science:

  • Hepatobiliary surgery
  • Interventional radiology
  • Oncology

Background:

  • Advanced hepatocellular carcinoma (HCC) can develop tumor thrombus (TT) in major vessels.
  • TT extending into the right atrium (RA) and inferior vena cava (IVC) presents significant management challenges and risks.

Observation:

  • A rare case of HCC with a large TT (85 × 45 mm) extending into the RA via the hepatic vein and IVC was encountered.
  • The patient underwent percutaneous microwave ablation for the TT and intrahepatic tumors.

Findings:

  • The percutaneous microwave ablation successfully reduced the size of the TT and intrahepatic tumors.
  • The patient maintained good condition and survived for 16 months post-treatment.
  • This represents the first reported instance of percutaneous microwave ablation for this specific condition.

Implications:

  • Percutaneous ablation may be a viable and effective treatment option for HCC with extensive TT into the RA and IVC.
  • This minimally invasive technique offers a potentially less risky alternative for managing complex HCC cases.
  • Further research and case studies are warranted to validate the long-term efficacy of this approach.
Abstract